A new antiviral compound developed by researchers can help protect the brain from the West Nile virus that can cause a serious neurological illness.
"We have identified a new antiviral compound that does not involve directly attacking a virus but stems viral invasion into the brain," said co-senior author Robyn Klein, professor of medicine at Washington University School of Medicine in St. Louis.
West Nile Virus
West Nile virus is an infection causing agent transmitted by mosquitoes. Most of the infected people do not display any signs or symptoms.
Advertisement
The compound, produced naturally in the body in response to infection, tightens the blood-brain barrier, making it harder for the virus to invade the brain.
The blood-brain barrier is a natural defence system that is supposed to keep pathogens out of the brain. No treatments exist for the virus, which crosses the blood-brain barrier in an estimated one percent of infected people, causing a neurologic illness such as encephalitis or meningitis that can be fatal.
![Role of Double-Stranded RNA in Antiviral Defense System in the Host Body Studied]( "Role of Double-Stranded RNA in Antiviral Defense System in the Host Body Studied")
A new study sheds more light on the role played by doubled stranded RNA (dsRNA) in sensing the presence of pathogens.
The scientists studied mice that lacked the antiviral compound. Compared with normal mice, the mice without the compound had higher levels of West Nile virus in the brain.
The researchers found the blood-brain barrier was much more permeable to the virus in these mice. The scientists then gave normal mice West Nile virus along with the anti-viral compound.
The mice received the antiviral compound at the start of the infection and two and four days later. Typically less than 20 percent of normal mice survive such a high dose of the virus, but survival rates rose to more than 40 percent after treatment with the antiviral compound.
The findings appeared online in the journal Science Translational Medicine.
Source: Medindia
Role of Double-Stranded RNA in Antiviral Defense System in the Host Body Studied
A new study sheds more light on the role played by doubled stranded RNA (dsRNA) in sensing the presence of pathogens.
Advertisement
The scientists studied mice that lacked the antiviral compound. Compared with normal mice, the mice without the compound had higher levels of West Nile virus in the brain.
The researchers found the blood-brain barrier was much more permeable to the virus in these mice. The scientists then gave normal mice West Nile virus along with the anti-viral compound.
The mice received the antiviral compound at the start of the infection and two and four days later. Typically less than 20 percent of normal mice survive such a high dose of the virus, but survival rates rose to more than 40 percent after treatment with the antiviral compound.
The findings appeared online in the journal Science Translational Medicine.
Source: Medindia
Mosquitoes Infected by Wolbachia More Likely to Transmit West Nile Virus to Humans
A team of researchers claim that mosquitoes infected with a bacteria Wolbachia are more likely to be infected by the West Nile virus and may transmit the disease to humans too
Advertisement
 Entecavir, An Effective Antiviral Drug, may Help Treat Hepatitis B Virus InfectionHepatitis B drug, entecavir, could be mass produced for only $36 per person per year. Combining mass vaccination with mass treatment would lower death rates. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Malaria parasites sync their molecular rhythms with the internal 24-hour clocks of their hosts, said researchers.
A latest research suggests that the quality of a person's post-work recovery in the evening can impact their mood when they resume work the next day.
Researchers are working on new strategies and solutions for sleep apnea to ward off a range of health risks including cognitive decline.
The scientists discovered that when the stem cells in the hair follicle are made softer, they have a higher chance of growing hair.
A combinatorial therapy provided promising beneficial results among people with ischemic stroke.